Allergan, Molecular Partners eye drug meets main goal in two studies
newsare.net
Allergan Plc and Molecular Partners AG said on Thursday their treatment for age-related macular degeneration met the main goal in two late-stage studies.Allergan, Molecular Partners eye drug meets main goal in two studies
Allergan Plc and Molecular Partners AG said on Thursday their treatment for age-related macular degeneration met the main goal in two late-stage studies. Read more